METiS Announces Pan-RAF Inhibitor License Agreement with Voronoi
13 Sep 2022 //
BUSINESSWIRE
NMPA approves Gloria`s anti-PD-1 drug; Brickell gains rights to DYRK1A inhibitor
01 Sep 2021 //
ENDPTS
13 Sep 2022 //
BUSINESSWIRE
01 Sep 2021 //
ENDPTS